In collaboration with @todaysclinical, we've developed a new educational guide exploring the fundamentals of MRD and MCED research, including key applications, workflow considerations, and analytical challenges. Download the guide to learn how researchers are leveraging #NGS and #liquidbiopsy approaches to advance #MRD and #MCED research: ow.ly/H5wo50ZYpsf
102
As new US biosecurity screening requirements are poised to reshape how the industry approaches DNA synthesis security, the industry is navigating an important question: How do we strengthen safeguards while continuing to accelerate scientific progress?
Adam Clore shares his perspective with Chemical & Engineering News in this timely look at what's next for sequence screening and the broader biosecurity landscape.
Read the story: ow.ly/ycug51088Lg
97
We've made it to PEGS Europe in Lisbon! Stop by Danaher booth #131 to discover how our nucleic acid solutions, gene synthesis expertise, and genome editing technologies can accelerate your next breakthrough. See you soon! 👋💥
2
123
“Cancer research is asking more of DNA than ever before. Researchers should be able to start with the biological question and access the right synthesis capability as their program develops—from high-diversity early work to dependable manufacturing for larger, longer-term needs. That's what full spectrum means at IDT: helping customers choose the right option for the work in front of them, with room to grow as their needs evolve, backed by the quality and reliability they expect.” —Steven Henck, IDT CTO
🌟Stop by booth #V-2266 to talk with IDT trusted experts at HLTH 2026.🌟
1
133
Integrated DNA Technologies retweeted
We’re delighted that @idtdna will be exhibiting at The Festival of Genomics and Biodata in January! Get your ticket to the UK’s biggest life sciences event now: hubs.la/Q04CBNLf0
#FOG2027
Wow iGEM’ers—what a week to remember. 🧬✨💖
We had a blast hearing about your brilliant projects and chatting about your big ideas for a better tomorrow. Your passion and creativity are rapidly advancing synbio, and our future has never looked brighter! We hope to see you next year!
Ground stop? Meet our backup flight plan! IDT's CTO Steven Henck is taking the #HLTH2026 panel mic for IDT President Jennifer Meade. Steven is joined by Dr Janet Jin of @Amgen, Dr Rick Baehner of @AbbottNews, and moderator Tom Cassels of @ManattHealth to discuss what it takes to move cancer innovation from discovery toward patient care, from high-sensitivity diagnostics to personalized therapies.
Steven’s focus: what research and development teams need at each stage—the right synthesis capability, NGS expertise, dependable manufacturing, and earlier collaboration—to accelerate promising programs at scale.
1
2
319
We're officially at #AMP2026 in Seattle! Stop by booth #1014 to explore how IDT's flexible, high-performance NGS solutions support cancer genomics, translational research, and precision oncology applications. We look forward to seeing you there!
We're heading to #PEGSEurope 2026! Meet us at Danaher booth #131 and discover how our high-quality nucleic acid solutions, gene synthesis expertise, and genome editing technologies can accelerate biologics discovery and therapeutic development.
Whether you're advancing antibody engineering, protein engineering, or exploring new therapeutic modalities, stop by to connect with our trusted experts and discuss your next breakthrough.
And don't miss our poster presentation showcasing strategies to support diverse library generation for a range of synthetic biology applications. Details below.
We look forward to seeing you in Lisbon! Learn more and book a meeting: ow.ly/Gjv35104gv5
1
120
Heading to HLTH 2026? IDT President Jennifer Meade will join leaders from Amgen, Abbott and Manatt Health for a panel on closing the gap between cancer innovation and patient care.
Jen will share what researchers need at each stage of a cancer research program—from rapid, high-diversity early design to dependable manufacturing—and how earlier collaboration can help teams reduce rework as they scale.
Learn more: ow.ly/kpxF5104acf
1
138
We’re SO EXCITED for the @iGEM Jamboree! Soon, we’ll be cheering on 400+ student teams from around the globe as they tackle real-world challenges using synthetic biology. Visit us at booth #X05—we’ll have games and trivia to test your knowledge, coloring to express yourself, and coffee to keep you going! Learn more here: idtb.io/plf59sx1
2
185
Explore the latest research from IDT scientists at AMP 2026! Our poster presentations span a range of topics and showcase applications, workflows, and performance data designed to support cancer genomics research. Watch the video for details. 🧬✨
Register here: idtb.io/fx6k75mv
119
Your cancer research demands speed, sensitivity and reproducibility, all at once. 🧬
At #HLTHUSA, stop by booth V-2266 to learn how IDT's full-spectrum DNA synthesis, NGS expertise and scientific partnership are designed to move your research quickly, early, and at scale with fewer restarts. Learn more here: hlth.com/events/usa/
1
130
Improving prime editing efficiency and finding the right base editor take more than individual tools. Together with Aldevron, we’re bringing complementary expertise across Danaher together to help researchers tackle these challenges.
Our expanded mRNA portfolio connects IDT’s CRISPR engineering and guide RNA design capabilities with Aldevron’s mRNA manufacturing expertise. Featuring PE Ultra mRNA and chemically modified Alt-R™ prime editing guide RNAs, the co-developed portfolio helps researchers simplify pegRNA design, evaluate base editing strategies, and advance precision editing programs with confidence.
Read more: idtb.io/3prnyqw0
1
134
Integrated DNA Technologies retweeted
Meet @idtdna on the FOG London exhibition floor this January! Connect with the team, explore their genomics solutions and exchange ideas with the life sciences community. Register here: hubs.la/Q04Bz2-d0
#FOG2027 #Genomics #Biodata #LifeSciences
Curious about IDT’s on-and-off target analysis services that have been in the news lately? Listen to Ashley Jacobi, director of applications and market development, give an overview of what you can expect when you work with her team to analyze your edits.
Learn more here: idtdna.com/pages/products/cr…
Explore the Nature publication on IDT’s UNCOVERseq™ here: nature.com/articles/s41467-0…
3
211
Join our corporate symposium at #AMP on enabling scalable molecular profiling in cancer research. This two-part session will explore automated workflows for hematologic malignancy research and emerging hybrid capture applications, with practical insights for scaling NGS-based studies. *You do not need to be attending AMP to attend! Register here: idtb.io/fx6k75mv
2
212
































